Anxiety is the most common mental health problem worldwide. Epidemiological studies
show that sleep disturbances, particularly insomnia, affect∼ 50% of individuals with anxiety …

Sleep is a complex physiological process and is a critical determinant of physical and
mental health. In the past decades, significant progress has been made in understanding …

Insomnia disorder comprises symptoms during night and day that strongly affect quality of
life and wellbeing. Prolonged sleep latency, difficulties to maintain sleep and early morning …

While sleep serves important regulatory functions for mental health, sleep disturbances, in
particular insomnia, may favour a state of allostatic overload impairing brain neuroplasticity …

Since ancient times it is known that melancholia and sleep disturbances co-occur. The
introduction of polysomnography into psychiatric research confirmed a disturbance of sleep …

Previous research has identified insomnia as a predictor for the onset of depression. The
aim of this meta-analysis is to investigate whether insomnia also predicts the onset of other …

This European guideline for the diagnosis and treatment of insomnia was developed by a
task force of the European Sleep Research Society, with the aim of providing clinical …

Evidence from human cohorts indicates that chronic insomnia is associated with higher risk
of cardiometabolic diseases (CMD), yet whether gut microbiota plays a role is unclear. Here …

Sleep reactivity is the trait‐like degree to which stress exposure disrupts sleep, resulting in
difficulty falling and staying asleep. Individuals with highly reactive sleep systems …

Gamma-aminobutyric acid (GABA) is a non-proteinogenic amino acid and is the main
inhibitory neurotransmitter in the mammalian brain. GABA's stress-reducing, and sleep …